Key Insights

Highlights

Treatment Research

2 treatments under study, led by Transfuse Plasma To High Inr Target

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 80/100

Termination Rate

100.0%

1 terminated out of 1 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

1Total
Phase 3 (1)

Trial Status

Terminated1

Clinical Trials (1)

Research Network

Common Treatments

  • Transfuse Plasma To High Inr Target1
  • Transfuse Plasma To Low Inr Target1

Active Sponsors

  • University of Colorado, Denver1

Top Investigators

Related Conditions

  • Liver Diseases1
  • Gastrointestinal Hemorrhage1
  • Respiratory Distress Syndrome Adult1

Activity Timeline